Genmont Biotech Incorporation

Genmont Biotech Inc.

Yi-Hsing Chen

Wan-Hua Tsai

Chia-Hsuan Chou

Ya-Hui Chen

Feng-Ching Hsieh

Chih-Yang Huang

Wen-Ling Yeh

Tsuei-Yin Huang

Tsuei Yin Huang

Wei-Wen Kuo

Bor-Show Tzang

Pei-Jane Tsai

Chien-Chen Wu

Yu-Hsin Lin

Chih-Ho Lai

Hui-Yu Huang

Ming-Shiou Jan

Yen-Wan Hsiao

Li-Jin Hsu

Ying-Ju Chiang

Hsiang-En Huang

Junko Sugawara

Wen-Wei Chang

Tzu-Chi Lou

Shiang-Suo Huang

Ting-Yun Shen

Yi-Hsin Wang

Po-Yung Chen

Chi Chien Lin

Yu-Jen Hsu

Present invention discloses acomposition comprisingGMNL-263 which is a strain of heat-killed dead bacteria and has the effect of lowering blood pressure by inhibition of proinflammatory cytokine IL-1β and enhancement the growth of, and saidcomposition is a pharmaceutical composition, nutritional supplement, health food or a combination thereof.

GMNL-263 for improving hypertension and its compositions thereof

The present invention relates to a plant growth regulator of elevating anti-stress ability and use thereof. The plant growth regulator, which is consisted offermenting culture solution, has excellent thermostability and safety without any side effect, significantly elevating ability against biotic and abiotic stresses. Therefore, thefermenting culture solution can be applied as the plant growth regulator or a use in preparation of a composition for elevating anti-stress ability of a plant.

Plant growth regulator of elevating anti-stress ability and use thereof

A composition havingstrain GMNL-662 for promoting bone regrowth is provided. Thestrain GMNL-662 has an ability to promote the expression of osteogenic genes, inhibit the expression of osteoclast related genes, and promote the expression of osteogenesis-related cytokine TGF-&#x3b2;, so that the bone loss is improved.

Method of promoting bone regrowth

The present invention relates to a topical composition of facilitating wound healing and reducing scars, which includes an inactivated culture ofspecies as an effective ingredient and can significantly facilitate wound healing as well as reducing scars, thereby can be applied to a method of facilitating wound healing and reducing scars.

Topical composition, pharmaceutical composition containing inactivated culture and method of facilitating wound healing and scar reduction using the same

The present invention provides a use for probiotic preparing skin care composition, wherein the probiotic comprises(GMNL-6) with preservation number of BCRC 910777 or CCTCC M 2017765. The composition may be externally-coating drug, pharmaceuticals for external use, care products for external use or cosmetics, and may achieve the effects of improving the skin conditions or aesthetic appearance by promoting secretion of collagen or expression of ceramide synthase.

Use of lactobacillus plantarum GMNL-6 composition for skin care

The present invention is related to astrain, composition and use thereof for treating autoimmune disease and related complications. The composition comprises at least one isolate ofstrain GMNL-32,strain GMNL-89 orstrain GMNL-263, and a pharmaceutical carrier, for treating syndromes and related complications of the autoimmune diseases.

strain, composition and use thereof for treating syndromes and related complications of autoimmune diseases

The present invention provides a pharmaceutical composition and a food product for inhibiting gastritis induced by gastric, comprisingselected from a group composed ofGM-020 (also known as GMNL-74) with deposited number CCTCC M203098;GMNL-185 with deposited number CCTCC M2017764; andGMNL-662 with deposited number CCTCC M2016571; and any two of the above bacteria.

Lactobacillus composition for inhibiting gastritis induced by gastric helicobacter pylori and use thereof

The present invention provides a composition for preventing stroke and ameliorating the severity of stroke and comprises an effective dose ofGMNL-89 andGMNL-133; the accession number ofGMNL-89 is CCTCC M207154 and the accession number ofGMNL-133 is CCTCC M2011331. The composition can be taken as a dietary supplement and be given continuously after a stroke, and said composition has the effects of ameliorating cerebral infarction, motor function, and intestinal microbiota after a stroke.

Use of a probiotic composition for preventing stroke and ameliorating the severity of stroke

The present invention relates to a probiotic composition for preventing, improving or alleviating pancreatic cancer and a method for preventing, improving or alleviating the pancreatic cancer and its complications using the probiotic composition. The probiotic composition, which is consisted of specific strains and specific ratio ofto, can significantly improve or alleviate various symptomatic indicators and severity of pancreatic cancer, thereby being applied on a method for preventing, improving or alleviating the pancreatic cancer and its complications using an oral composition including thestrains.

Probiotic composition for preventing, improving or alleviating pancreatic cancer and application thereof

Use offor preparing for a combination for alleviating axillary osmidrosis is provided in the present invention, whereinrefers in particular toGMNL-653, featuring abilities of aggregating and inhibiting pathogens of axillary osmidrosis for alleviation of armpit odors and presented as a topical medication or a combination of cosmetics in which fragrance is added.

Use ofGMNL-653 for preparing for a composition for alleviating axillary osmidrosis

A composition is used for prevention or treatment of bacterial vaginosis (BV) and regulation of vaginal immunity and said composition with effective amount is selected from the groups comprisingGMNL-680 andGMNL-682; the composition of the present invention is used to prevent and treat bacterial vaginosis by inhibition of the growth of pathogens and regulation of the expression of immunoregulators and is prepared in the forms of pharmaceutical compositions, food or other combinations thereof.

Lactobacillus composition for prevention and treatment of bacterial vaginosis

A method and a composition having thestrain GMNL-653 for treating psoriasis is provided. Thestrain GMNL-653 has anti-inflammation properties, and inhibits the secretion of cytokine IL-6 and IL-17, so that the psoriasis symptoms caused by over-inflammation are improved/relieved.

Method of treating psoriasis

A method for inhibiting bacterial adhesion of oral pathogens, comprising administering a heat-inactivatedstrain to a subject in need to inhibit bacterial adhesion of oral pathogens is disclosed. Thestrain is selected fromGMNL-143,GMNL-164 orGMNL-464. A composition for inhibiting bacterial adhesion of oral pathogens is also disclosed.

Method and composition for inhibiting bacterial adhesion of oral pathogens

A use of astrain to prepare a composition for resisting bone loss is provided. Thestrain GMNL-653 is capable of promoting the expression of TGF-&#x3b2; and IL-10, while inhibiting the expression of osteoclast related genes and reducing the content of IL-17A in serum, so that the bone loss is slowed down.

Method of treating bone loss

A composition ofGMNL-296 and a use ofGMNL-296 for producing a composition to improve the infection symptoms ofare provided. TheGMNL-296 is to promote the expression of anti-inflammatory cytokine IL-10 and Treg cell related transcription factors, so that the infection symptoms of weight loss and intestinal abnormalities are improved.

Growing community of inventors

Tainan, Taiwan

Yi-Hsing Chen